Lenalidomide as second-line therapy for advanced hepatocellular carcinoma (HCC): biomarker exploration
Shao, Y-Y., Chen, B-B., Lin, Z-Z., Hsu, C-H., Wang, M-J., Cheng, A-L., Hsu, C.Volume:
27
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw371.99
Date:
October, 2016
File:
PDF, 34 KB
english, 2016